Vaccine coagulation disorders

Last updated on: 27.01.2021

Dieser Artikel auf Deutsch

Definition
This section has been translated automatically.

Patients with coagulation disorders or bleeding tendencies can almost always be vaccinated subcutaneously (s.c.). The s.c. application is covered by the approval for most vaccines or another vaccine against the corresponding pathogen with s.c. approval can be found. If there is no approval for s.c. administration, vaccination may also be administered intramuscularly (i.m.) with a very fine injection needle and subsequent firm compression of the injection site for at least 2 minutes, if an individual risk-benefit assessment is in favour of vaccination.[1].

The following table provides information on the recommended or prescribed route of injection according to pathogen, as well as further information on injections in the case of coagulation disorders or bleeding tendency from the respective expert information for all vaccines currently available in Germany. If indicated in the SmPC, alternative injection routes are also listed. No indication in the field "Alternative route of injection" means that there is no information on this in the respective SmPC.

Literature
This section has been translated automatically.

  1. Communication of the Robert Koch Institute (retrieved on 25.1.2021).

Last updated on: 27.01.2021

Articlecontent